ADVANCED ONCOTHER. Aktie - Unternehmensdaten & Kurse - GB00BD6SX109 | goSPATZ

ADVANCED ONCOTHER.

Share · GB00BD6SX109 · A2AL9X (XLON)

Overview Financial Indicators

No Price

n/a

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-	-	-	-	0,00 %	0,00 %	-99,93 %

Company Profile for ADVANCED ONCOTHER. Share

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Company Data

Name ADVANCED ONCOTHER.

Company Advanced Oncotherapy plc

Website https://www.avoplc.com

Primary Exchange

London

WKN A2AL9X

ISIN GB00BD6SX109

Asset Class Share

Sector Healthcare

Industry Medical - Devices

CEO Mr. Nicolas Serandour

Country United Kingdom

Currency GBP

Employees 0,2 T

Address 4 Tenterden Street, W1S 1TE London

IPO Date 2006-08-04

Stock Splits

Date	Split
01.07.2016	1:25

Ticker Symbols

Name	Symbol
London	AVO.L

More Shares

Investors who ADVANCED ONCOTHER. hold also have the following shares in their portfolio:

SPAREBANK 1 23/UND. FLR Bond

XT.-MSCINORD 1CEOA ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025